Repeated Molecular Testing Indicates Dynamic Disease Profile in Patients With PV, ET

Patients with polycythemia vera (PV) and essential thrombocythemia (ET) require repeated molecular testing and improved prognostic tools.

Related Keywords

Poland , ,World Health Organization ,World Health ,Pv ,Pet ,Molecular Testing ,Essential Thrombocythemia ,